• 한국미생물학회:학술대회논문집
• /
• 한국미생물학회 2003년도 International Meeting of the Microbiological Society of Korea
• /
• pp.80-81
• /
• 2003

• 한국축산식품학회지
• /
• 제37권1호
• /
• pp.1-9
• /
• 2017

The rotavirus-induced diarrhea of human and animal neonates is a major public health concern worldwide. Until recently, no effective therapy is available to specifically inactivate the rotavirion particles within the gut. Passive immunotherapy by oral administration of chicken egg yolk antibody (IgY) has emerged of late as a fresh alternative strategy to control infectious diseases of the alimentary tract and has been applied in the treatment of diarrhea due to rotavirus infection. The purpose of this concise review is to evaluate evidence on the properties and performance of anti-rotavirus immunoglobulin Y (IgY) for prevention and treatment of rotavirus diarrhea in human and animal neonates. A survey of relevant anti-rotavirus IgY basic studies and clinical trials among neonatal animals (since 1994-2015) and humans (since 1982-2015) have been reviewed and briefly summarized. Our analysis of a number of rotavirus investigations involving animal and human clinical trials revealed that anti-rotavirus IgY significantly reduced the severity of clinical manifestation of diarrhea among IgY-treated subjects relative to a corresponding control or placebo group. The accumulated information as a whole depicts oral IgY to be a safe and efficacious option for treatment of rotavirus diarrhea in neonates. There is however a clear need for more randomized, placebo controlled and double-blind trials with bigger sample size to further solidify and confirm claims of efficacy and safety in controlling diarrhea caused by rotavirus infection especially among human infants with health issues such as low birth weights or compromised immunity in whom it is most needed.

• Clinical and Experimental Pediatrics
• /
• 제56권11호
• /
• pp.465-473
• /
• 2013

The epidemiology of human group A rotavirus was analyzed by examining genotypic data acquired from 1989 to 2009 in South Korea. This information was derived from all the available published articles on rotavirus studies in South Korea, retrieved from both the PubMed and KoreaMed databases. Four common G types (G1, G2, G3, and G4) and three common P types (P[8], P[4], and P[6]) accounted for approximately 93% and 99% of the rotavirus reports, respectively. The G9 type was frequently detected after 2000, and because of this prevalence, it is considered to be the fifth most important G type rotavirus after the G1-G4 genotypes. Less common G types of the virus such as G12, G11, and G10 were detected in some geographic settings, and it is important to consider the context of these subtypes and their epidemiological significance. The P[9] virus genotype was observed in the study and has been discussed in many other studies; however, the P[3], P[10] and P[25] genotypes were rarely detected in the epidemiological research. In general, the distributions of the G and P genotypes showed temporal and geographical fluctuations, and a nationwide rotavirus vaccine program that targeted these genotypes demonstrated effectiveness in protecting against the circulating rotavirus strains. However, further analysis is needed to determine the true long-term effectiveness of these vaccines; the analysis should also consider the unexpected effects of vaccinations, such as vaccineinduced diseases, herd immunity, and changes in host susceptibilities.

• 미생물학회지
• /
• 제30권5호
• /
• pp.397-402
• /
• 1992

서울지역의 소아설사환자가 가검물로부터 분리한 로타바이러스의 VP7을 코딩하는 RNA분절 cDNA를 합성한 후 로타바이러스 혈청형1인 WA1과 RE9의 아홉 번째 RNA분절과 비교하였더니 90%이상의 유사성을 보였다. 염기서열로부터 유추된 아미노산 서열중 혈청간에 변이가 많은 VR5와 VR8 지역을 비교한 결과 역시 혈청형 1인 RE9과 WA1 바이러스주와 매우 높은 유사성을 지님을 알 수 있었다.

• Journal of Microbiology and Biotechnology
• /
• 제12권3호
• /
• pp.463-469
• /
• 2002

Rotaviruses are the world-wide leading causative agents of severe dehydrating gastroenteritis in young children and animals. The outer capsid glycoprotein VP7 and inner capsid glycoprotein VP6 of rotaviruses are highly antigenic and immunogenic. An SFV-based expression system has recently emerged as a useful tool for heterologous protein production in mammalian cells, exhibiting a much more efficient performance compared to other gene expression systems. Accordingly, the current study adopted an SFV-based expression system to express the VP7 of a group A human rotavirus from a Korean isolate, and the VP6 of a group B bovine rotavirus from a Korean isolate, in mammalian cells. The genes of the VP6 and VP7 were inserted into the SFV expression vector pSFV-1. The RNA was transcribed in vitro from pSFV-VP6 and pSFV-VP7 using SP6 polymerase. Each RNA was then electroporated into BHK-21 cells along with pSFV-helper RNA containing the structural protein gene without the packaging signal. The expression of VP6 and VP7 in the cytoplasm was then detected by immunocytochemistry. The recombinant virus was harvested by ultracentrifugation and examined under electron microscopy. After infecting BHK-21 cells with the defective viruses, the expressed proteins were separated by SDS-PAGE and analyzed by a Western blot. The results indicate that an SFV-based expression system fur the VP6 and VP7 of rotaviruses is an efficient tool for developing a diagnostic kit and/or preventive vaccine.

• 대한바이러스학회지
• /
• 제29권2호
• /
• pp.75-86
• /
• 1999

Rotaviruses belong to Reoviridae causes diarrhea in human beings as well as domestic animals. This study was conducted to see what type of human rotaviruses are distributed in Seoul and Kyung-gi province. Twenty two of 81 patients showed rotavirus positive with diagnostic kit and RNA electropherosis. We isolated all of rotaviruses from the patients. Electropherotypes of 22 isolates showed 4:2:3:2 pattern whereas those migration patterns were long type. All of those isolates belonged to group A. Twenty out of 22 isolates reacted with monoclonal antibodies specific to G1, P1A and subgroup II, whereas rest of them, A-29 and K-30 reacted with subgroup I specific monoclonal antibody. The nucleotide sequence of an isolate K-21 showed $98{\sim}100%$ and $90{\sim}96%$ homologies with those of Wa and KU strain, respectively.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제9권2호
• /
• pp.147-152
• /
• 2006

목 적: 최근 새로이 개발된 두 개의 백신(Rotarix, RotaTeq)의 효능은 지역사회에 유행하는 로타바이러스 genotype에 따라 영향을 받을 수 있다. 저자는 제주지역에 유행하는 로타바이러스 genotype의 분포를 알아보고자 하였다. 방 법: 2005년 7월부터 2006년 6월까지 급성 설사로 제주대학교병원 소아과에 내원 또는 입원하여 로타바이러스 위장관염으로 진단 받았던 154명 중 81명에서 대변 검체를 수집하였다. 대변 검체에서 RNA를 추출하여 역전사-중합효소 반응(reverse transcription-polymerase chain reaction, RT-PCR)을 시행하여 로타바이러스 VP7 genes을 증폭하였으며 여섯개(1, 2, 3, 4, 8, 9)의 G 유전형을 확인하였다. 결 과: 역전사-중합효소 반응을 시행한 81개의 대변 검체에서 모두 VP7유전자가 증폭됨을 확인하였다. 이들 검체에서 VP 7 단백의 유전형을 보면 G1이 53예(65.5%)로 가장 많았고 그 다음으로 G2 12예(14.8%), G3 11예(13.6%), G8 1예(1.2%), G9 1예(1.2%), G4 0예(0%) 그리고 G1/G3 혼합형이 3예(3.7%)로 나타났다. 결 론: 제주 지역의 로타바이러스 VP7 genotypes의 분포는 국내의 다른 지역들과 달랐으며, G1 유전형이 가장 흔하게 검출되었다.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제4권1호
• /
• pp.34-40
• /
• 2001

목 적: 로타바이러스에 의한 장염의 진단에서 RT-PCR을 ELISA나 LA와 비교하여 각 검사의 효율을 비교하였다. 방 법: 설사증을 주소로 내원한 유소아의 대변에서 ELISA나 LA에 의한 로타바이러스 항원 검출률과 RT-PCR에 의한 로타바이러스 유전자 검출률을 비교하였다. 결 과: 대변에서 로타바이러스 감염을 진단하는데 있어 ELISA는 LA보다 우월하며 RT-PCR과 특이도의 의미있는 차이없이 상당한 일치를 보였다. 결 론: 로타바이러스 장염의 진단에서 ELISA는 LA보다 우월하며 RT-PCR은 ELISA 보다 의미있게 우월하지는 않았다.

• Pediatric Infection and Vaccine
• /
• 제22권2호
• /
• pp.81-90
• /
• 2015

목적: 한국에 백신이 도입된 이후 장염으로 입원한 소아에서 확인된 로타바이러스 유전형의 분포를 알아보고자 하였다. 방법: 2009년 8월부터 2013년 6월 사이에 급성 위장관염으로 입원한 소아에게서 수집된 201개의 로타바이러스 양성 대변 검체를 대상으로 로타바이러스 유전형 분석이 시행되었다. 결과: G 유전형은 G9 (33.3%), G1 (22.4%), G3 (15.9%), G2 (6.0%), G4 (3.0%), G10 (1.5%)이었고 혼합형(15.4%) 및 분류불능(2.5%)이 관찰되었다. P 유전형은 P[4] (45.3%)과 P[8] (43.8%)가 주로 검출되었고 혼합형(10.4%)과 P[2] (0.5%)가 발견되었다. G9P[4] 유전형이 2010/2011년에 자주 검출되었으나 이후에 G1P[8] 유전형이 주로 검출되었다. 결론: 로타바이러스 백신 도입 이후 2009-2013년 동안 G1, G3 및 G9이 번갈아가며 주로 검출되는 것을 확인하였다.

• Pediatric Infection and Vaccine
• /
• 제15권1호
• /
• pp.1-4
• /
• 2008

Immunizations are among the most cost-effective and widely used public health interventions. This is a report a revision of recommendation of immunization for children by Korean Pediatric Society. Immunization. Vaccines were divided into 4 groups. 1) Vaccines that are recommended to all infants and children (BCG, hepatitis B vaccine, DTaP, Td, Polio vaccine, Japanese encephalitis vaccine, MMR, varicella vaccine, influenza vaccine [6-23 months of age], H. influenzae type b vaccine), 2) those that can be administered to all infants and children, but decision of administration is made by parents (pneumococcal conjugate vaccine, hepatitis A vaccine, influenza vaccine [healthy children ${\geq}24$ months of age], rotavirus vaccine, human papilloma virus vaccine), 3) those that should be given to high risk group (pneumococcal polysaccharide vaccine [high risk patients ${\geq}24$ months of age], influenza vaccine [high risk patients ${\geq}24$ months of age], typhoid vaccine), and 4) those administered for control of outbreaks or prevention of emerging infectious diseases. Immunization schedule recommended by Korean Pediatric Society in 2008 is presented.